BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31520369)

  • 1. Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging.
    Abdo RA; Lamare F; Fernandez P; Bentourkia M
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):981-993. PubMed ID: 31520369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
    Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
    Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
    J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
    Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.
    Swanson KR; Chakraborty G; Wang CH; Rockne R; Harpold HL; Muzi M; Adamsen TC; Krohn KA; Spence AM
    J Nucl Med; 2009 Jan; 50(1):36-44. PubMed ID: 19091885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
    Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
    Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study.
    Ponte KF; Berro DH; Collet S; Constans JM; Emery E; Valable S; Guillamo JS
    J Nucl Med; 2017 Oct; 58(10):1574-1579. PubMed ID: 28596159
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Grkovski M; Emmas SA; Carlin SD
    J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
    Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
    Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
    Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
    Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Analysis of Dynamic
    Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
    J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the scan time point when assessing hypoxia in
    Kobayashi K; Manabe O; Hirata K; Yamaguchi S; Kobayashi H; Terasaka S; Toyonaga T; Furuya S; Magota K; Kuge Y; Kudo K; Shiga T; Tamaki N
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1833-1842. PubMed ID: 31781832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.
    Bourigault P; Skwarski M; Macpherson RE; Higgins GS; McGowan DR
    Sci Rep; 2022 Dec; 12(1):21746. PubMed ID: 36526815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
    Toyonaga T; Hirata K; Yamaguchi S; Hatanaka KC; Yuzawa S; Manabe O; Kobayashi K; Watanabe S; Shiga T; Terasaka S; Kobayashi H; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1469-76. PubMed ID: 26841941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
    J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Hypoxia in Human Glioblastoma using PET with 18F-FMISO.
    Abdo RA; Lamare F; Fernandez P; Bentourkia M
    Nucl Med Mol Imaging; 2021 Jun; 55(3):107-115. PubMed ID: 34109007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.